Resultados de procura - Carl D. Regillo

Limitar resultados
  1. 1
    Baseline Predictors of 12-Month Treatment Response to Ranibizumab in Patients With Wet Age-Related Macular Degeneration

    Baseline Predictors of 12-Month Treatment Response to Ranibizumab in Patients With Wet Age-Related Macular Degeneration por Carl D. Regillo, Brandon Busbee, Allen C. Ho, Beiying Ding, Zdenka Hašková

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  2. 2
    Long-term (60-month) results for the implantable miniature telescope: efficacy and safety outcomes stratified by age in patients with end-stage age-related macular degeneration

    Long-term (60-month) results for the implantable miniature telescope: efficacy and safety outcomes stratified by age in patients with end-stage age-related macular degeneration por David S. Boyer, K. Bailey Freund, Carl D. Regillo, Marc H. Levy, Sumit Garg

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    Predictors of Diabetic Macular Edema Treatment Frequency with Ranibizumab During the Open-Label Extension of the RIDE and RISE Trials

    Predictors of Diabetic Macular Edema Treatment Frequency with Ranibizumab During the Open-Label Extension of the RIDE and RISE Trials por Charles C. Wykoff, Michael J. Elman, Carl D. Regillo, Beiying Ding, Na Lu, Ivaylo Stoilov

    Publicado 2016
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Economic Evaluation of a Home-Based Age-Related Macular Degeneration Monitoring System

    Economic Evaluation of a Home-Based Age-Related Macular Degeneration Monitoring System por John S. Wittenborn, Traci E. Clemons, Carl D. Regillo, Nadim Rayess, Danielle Kruger, David B. Rein

    Publicado 2017
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Twenty-four-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular Degeneration

    Twenty-four-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular Degeneration por Allen C. Ho, Brandon Busbee, Carl D. Regillo, Mark R. Wieland, Sherri A. Van Everen, Zhengrong Li, Roman G. Rubio, Phillip Lai

    Publicado 2014
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Clinical Presentation of Rhegmatogenous Retinal Detachment during the COVID-19 Pandemic

    Clinical Presentation of Rhegmatogenous Retinal Detachment during the COVID-19 Pandemic por Luv Patel, Travis Peck, Matthew R. Starr, Michael J. Ammar, Khan Ma, Yoshihiro Yonekawa, Michael A. Klufas, Carl D. Regillo, Allen C. Ho, David Xu

    Publicado 2020
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    ASSOCIATION BETWEEN HIGH-RISK DISEASE LOCI AND RESPONSE TO ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR WET AGE-RELATED MACULAR DEGENERATION

    ASSOCIATION BETWEEN HIGH-RISK DISEASE LOCI AND RESPONSE TO ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR WET AGE-RELATED MACULAR DEGENERATION por Anton Orlin, Dexter Hadley, Woohyok Chang, Allen C. Ho, Gary C. Brown, Richard Kaiser, Carl D. Regillo, Ashlee N. Godshalk, Audun Lier, Brian Kaderli, Dwight Stambolian

    Publicado 2011
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Outcomes of Eyes Lost to Follow-up with Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation versus Intravitreal Anti–Vascular Endothelial Growth Factor

    Outcomes of Eyes Lost to Follow-up with Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation versus Intravitreal Anti–Vascular Endothelial Growth Factor por Anthony Obeid, Daniel Su, Samir Patel, Joshua H. Uhr, Durga S. Borkar, Xinxiao Gao, Mitchell S. Fineman, Carl D. Regillo, Joseph I. Maguire, Sunir J. Garg, Jason Hsu

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    Safety and efficacy of ixoberogene soroparvovec in neovascular age-related macular degeneration in the United States (OPTIC): a prospective, two-year, multicentre phase 1 study

    Safety and efficacy of ixoberogene soroparvovec in neovascular age-related macular degeneration in the United States (OPTIC): a prospective, two-year, multicentre phase 1 study por Arshad M. Khanani, David S. Boyer, Charles C. Wykoff, Carl D. Regillo, Brandon Busbee, Dante J. Pieramici, Carl J. Danzig, Brian C. Joondeph, James C. Major, Adam Turpcu, Szilárd Kiss

    Publicado 2023
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Juxtapapillary capillary hemangiomas

    Juxtapapillary capillary hemangiomas por Cathleen M. McCabe, Harry W. Flynn, Carol L Shields, Jerry A. Shields, Carl D Regillo, H. Richard McDonald, María H. Berrocal, J. Donald M. Gass, William F. Mieler

    Publicado 2000
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Sustained Visual Acuity Loss in the Comparison of Age-Related Macular Degeneration Treatments Trials

    Sustained Visual Acuity Loss in the Comparison of Age-Related Macular Degeneration Treatments Trials por Gui‐shuang Ying, Benjamin J. Kim, Maureen G. Maguire, Jiayan Huang, Ebenezer Daniel, Glenn J. Jaffe, Juan E. Grunwald, Kevin J. Blinder, Christina J. Flaxel, Firas M. Rahhal, Carl D. Regillo, Daniel Martín

    Publicado 2014
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    TREAT-AND-EXTEND REGIMENS WITH ANTI-VEGF AGENTS IN RETINAL DISEASES

    TREAT-AND-EXTEND REGIMENS WITH ANTI-VEGF AGENTS IN RETINAL DISEASES por K. Bailey Freund, Jean‐François Korobelnik, Robert G. Devenyi, Carsten Framme, John Galic, Edward N. Herbert, Hans Hoerauf, Paolo Lanzetta, Stephan Michels, Paul Mitchell, Jordi Monés, Carl D. Regillo, Ramin Tadayoni, James Talks, Sebastián Wolf

    Publicado 2015
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  13. 13
    KESTREL and KITE Phase 3 Studies: 100-Week Results With Brolucizumab in Patients With Diabetic Macular Edema

    KESTREL and KITE Phase 3 Studies: 100-Week Results With Brolucizumab in Patients With Diabetic Macular Edema por Charles C. Wykoff, Justus G. Garweg, Carl D. Regillo, Eric H. Souied, Sebastián Wolf, Dilsher S. Dhoot, Hansjuergen Agostini, Andrew Chang, Augustinus Laude, J Wachtlin, Lidija Kovacic, Lixin Wang, Ying Wang, Emmanuel Bouillaud, David M. Brown

    Publicado 2023
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration

    The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration por Peter A. Campochiaro, Dennis M. Marcus, Carl C. Awh, Carl D. Regillo, Anthony P. Adamis, Vladimir Bantseev, Ya‐Wen Chiang, Jason S. Ehrlich, Signe Erickson, William D. Hanley, Joshua Horvath, Katie F. Maass, Natasha Singh, Fan Tang, Giulio Barteselli

    Publicado 2019
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Bacterial Dispersion Associated With Various Patient Face Mask Designs During Simulated Intravitreal Injections

    Bacterial Dispersion Associated With Various Patient Face Mask Designs During Simulated Intravitreal Injections por Samir Patel, Raziyeh Mahmoudzadeh, Mirataollah Salabati, Rebecca R. Soares, John W. Hinkle, Jason Hsu, Sunir J. Garg, Carl D. Regillo, Allen C. Ho, Michael N. Cohen, Khan Ma, Yoshihiro Yonekawa, Allen Chiang, Omesh P. Gupta, Ajay E. Kuriyan

    Publicado 2020
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration

    Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration por Brian L. Yaspan, David F. Williams, Frank G. Holz, Carl D. Regillo, Zhengrong Li, Amy Dressen, Menno van Lookeren Campagne, Kha Le, Robert Graham, Tatiana Beres, Tushar Bhangale, Lee Honigberg, Ashley Smith, Erin C. Henry, Carole Ho, Erich C. Strauss

    Publicado 2017
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    Primary Retinal Detachment Outcomes Study Report Number 2

    Primary Retinal Detachment Outcomes Study Report Number 2 por Edwin H. Ryan, Claire Ryan, Nora J. Forbes, Yoshihiro Yonekawa, Sushant Wagley, Robert A. Mittra, D. Wilkin Parke, Daniel P. Joseph, Geoffrey G. Emerson, Gaurav K. Shah, Kevin J. Blinder, Antonio Capone, George A. Williams, Dean Eliott, Omesh P. Gupta, Jason Hsu, Carl D. Regillo

    Publicado 2020
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    Artificial Intelligence Detection of Diabetic Retinopathy

    Artificial Intelligence Detection of Diabetic Retinopathy por Jennifer I. Lim, Carl D. Regillo, Srinivas R. Sadda, Eli Ipp, Malavika Bhaskaranand, Chaithanya Ramachandra, Kaushal Solanki, Harvey Dubiner, Grace A. Levy-Clarke, Richard D. Pesavento, Mark D. Sherman, Steven Silverstein, Brian Kim, Gerald B. Walman, Barbara A. Blodi, Amitha Domalpally, Susan Reed, James Reimers, Kris Lang, Holy Cohn, Ruth Shaw, Sheila Watson, Andrew Ewen, Nancy Barrett, Maria Swift, Jeffrey Gornbein

    Publicado 2022
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    Five-Year Safety and Performance Results from the Argus II Retinal Prosthesis System Clinical Trial

    Five-Year Safety and Performance Results from the Argus II Retinal Prosthesis System Clinical Trial por Lyndon da Cruz, Jessy D. Dorn, Mark S. Humayun, Gislin Dagnelie, James T. Handa, Pierre‐Olivier Barale, José‐Alain Sahel, Paulo Stanga, Farhad Hafezi, Avinoam B. Safran, Joël Salzmann, Arturo Santos, David G. Birch, Rand Spencer, Artur V. Cideciyan, Eugene de Juan, Jacque L. Duncan, Dean Eliott, Amani A. Fawzi, Lisa C. Olmos de Koo, Allen C. Ho, Gary C. Brown, Julia A. Haller, Carl D. Regillo, Lucian V. Del Priore, Aries Arditi, Robert J. Greenberg

    Publicado 2016
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    Long-Term Results from an Epiretinal Prosthesis to Restore Sight to the Blind

    Long-Term Results from an Epiretinal Prosthesis to Restore Sight to the Blind por Allen C. Ho, Mark S. Humayun, Jessy D. Dorn, Lyndon da Cruz, Gislin Dagnelie, James T. Handa, Pierre‐Olivier Barale, José‐Alain Sahel, Paulo Stanga, Farhad Hafezi, Avinoam B. Safran, Joël Salzmann, Arturo Santos, David G. Birch, Rand Spencer, Artur V. Cideciyan, Eugene de Juan, Jacque L. Duncan, Dean Eliott, Amani A. Fawzi, Lisa C. Olmos de Koo, Gary C. Brown, Julia A. Haller, Carl D. Regillo, Lucian V. Del Priore, Aries Arditi, Duane R. Geruschat, Robert J. Greenberg

    Publicado 2015
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: